Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, Type 2, Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01392027
What this trial is testing

Biospecimens for Identification of Diseases of the Pancreas.

Who this might be right for
Pancreatic CancerChronic PancreatitisType II Diabetes+2 more
University of Michigan 712
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Not applicableUnknownNCT04164602
What this trial is testing

The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly

Who this might be right for
Diabetes MellitusDiabetesDiabetes Mellitus, Type 2+5 more
University of Pecs 2,522
Not applicableStudy completedNCT02555631
What this trial is testing

PowerUp for Health: A Diabetes Prevention Program for Men

Who this might be right for
Type 2 DiabetesMen
Albert Einstein College of Medicine 29
Not applicableEnded earlyNCT05315908
What this trial is testing

COVID-19 Testing in Underserved and Vulnerable Populations

Who this might be right for
Heart FailureCoronary Artery DiseaseCancer+5 more
Jesse Nodora 9,120
Not applicableUnknownNCT05547594
What this trial is testing

Prehabilitation in Patients With Cancer and Type 2 Diabetes

Who this might be right for
CancerType 2 Diabetes
University of Greenwich 60
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Not applicableStudy completedNCT06583161
What this trial is testing

Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)

Who this might be right for
Myocardial InfarctionIschemic StrokeAngina Pectoris+12 more
Harvard School of Public Health (HSPH) 503,325
Not applicableLooking for participantsNCT03568630
What this trial is testing

Blood Markers of Early Pancreas Cancer

Who this might be right for
Diabetes Mellitus, Type 2PreDiabetesPancreas Cyst+3 more
University of Nebraska 1,250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748208
What this trial is testing

A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes

Who this might be right for
Breast CancerDiabetes Type II
Hoffmann-La Roche 40
Not applicableStudy completedNCT04938869
What this trial is testing

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmType 2 Diabetes Mellitus
Ohio State University Comprehensive Cancer Center 3
Not applicableStudy completedNCT06333665
What this trial is testing

PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy

Who this might be right for
Esophageal Squamous Cell CarcinomaSurgery
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 605
Not applicableStudy completedNCT04569630
What this trial is testing

The HEADWIND Study - Part 2

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Insel Gruppe AG, University Hospital Bern 22
Not applicableLooking for participantsNCT06976073
What this trial is testing

Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

Who this might be right for
Diabetes Mellitus, Type 2Diabetic FootPeripheral Arterial Disease+2 more
HJN Sverige AB/Neko Health 8,000
Not applicableUnknownNCT05505864
What this trial is testing

Assessing Sedentary Behaviour in Adults With Type 2 Diabetes - A Randomized Controlled Trial

Who this might be right for
Sedentary BehaviorDiabetes Mellitus, Type 2Adult ALL
Western University 52
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableUnknownNCT01637350
What this trial is testing

Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableStudy completedNCT05565534
What this trial is testing

Diabetes Care for Breast Cancer Patients

Who this might be right for
Breast CancerPreDiabetesType 2 Diabetes
Weill Medical College of Cornell University 74
Not applicableStudy completedNCT04572165
What this trial is testing

Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 194,928
Not applicableStudy completedNCT02773095
What this trial is testing

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Who this might be right for
Cardiovascular DiseaseDiabetes Type IIBreast Cancer+1 more
Boston University 966
Next Page